Scilex Holding Company Earnings Per Share (Diluted)
Scilex Holding Company (SCLX) reported Earnings Per Share (Diluted) of -$16.65 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-14
- Scilex Holding Company earnings per share, diluted for the quarter ending 2026-06-30 was -$16.65.
- Scilex Holding Company earnings per share, diluted for the quarter ending 2026-03-31 was -$6.28.
- Scilex Holding Company earnings per share, diluted for the quarter ending 2025-12-31 was -$3533.08.
- Scilex Holding Company earnings per share, diluted for the quarter ending 2025-09-30 was -$22.17.
- Scilex Holding Company earnings per share, diluted for fiscal 2025 was -$36.48.
- Scilex Holding Company earnings per share, diluted for fiscal 2024 was -$8.05.
- Scilex Holding Company earnings per share, diluted for fiscal 2023 was -$1.28.
- Scilex Holding Company earnings per share, diluted for fiscal 2022 was -$0.17.
| Period end | Earnings Per Share, Diluted 1 month | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 4 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 7 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 10 month | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$16.65 10-Q · filed 2026-08-14 | -$22.93 10-Q · filed 2026-08-14 | -$41.57 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$129.92 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||||||
| 2026-03-31 | -$6.28 10-Q · filed 2026-05-20 | -$22.14 derived: net income ÷ weighted average shares · filed 2026-05-20 | -$144.80 derived: net income ÷ weighted average shares · filed 2026-05-20 | -$90.71 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||||||
| 2025-12-31 | -$3533.08 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$27683.64 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$97.21 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$36.48 10-K · filed 2026-04-10 | ||||||||
| 2025-09-30 | -$22.17 10-Q · filed 2025-11-14 | -$59.16 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$31.88 10-Q · filed 2025-11-14 | -$66.34 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||||||
| 2025-06-30 | -$7.42 10-Q · filed 2026-08-14 | -$9.68 10-Q · filed 2026-08-14 | -$16.50 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$22.75 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||||||
| 2025-03-31 | -$2.26 10-Q · filed 2026-05-20 | -$7.15 derived: net income ÷ weighted average shares · filed 2026-05-20 | -$11.85 derived: net income ÷ weighted average shares · filed 2026-05-20 | -$28.75 derived: net income ÷ weighted average shares · filed 2026-05-20 | ||||||||
| 2024-12-31 | -$614.25 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1212.90 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$4591.39 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$8.05 10-K · filed 2026-04-10 | -$0.61 10-K · filed 2025-03-31 | |||||||
| 2024-09-30 | -$0.58 10-Q · filed 2025-11-14 | -$0.03 10-Q · filed 2025-01-17 | -$6737.84 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$12.77 10-Q · filed 2025-11-14 | -$0.56 10-Q · filed 2025-01-17 | |||||||
| 2024-06-30 | -$7.67 10-Q · filed 2025-08-13 | -$0.31 10-Q · filed 2024-08-13 | -$15.49 10-Q · filed 2025-08-13 | -$0.56 10-Q · filed 2024-08-13 | ||||||||
| 2024-03-31 | -$8.33 10-Q · filed 2025-05-14 | -$0.24 10-Q · filed 2024-05-13 | ||||||||||
| 2023-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.78 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$1.28 10-K · filed 2025-03-31 | ||||||||
| 2023-09-30 | -$0.63 10-Q · filed 2025-01-17 | -$440.30 derived: net income ÷ weighted average shares · filed 2025-01-17 | -$1.03 10-Q · filed 2025-01-17 | -$3.21 derived: net income ÷ weighted average shares · filed 2025-01-17 | ||||||||
| 2023-06-30 | -$0.19 10-Q · filed 2024-08-13 | -$0.40 10-Q · filed 2024-08-13 | -$1.64 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$0.79 derived: net income ÷ weighted average shares · filed 2024-08-13 | ||||||||
| 2023-03-31 | -$0.22 10-Q · filed 2024-05-13 | -$0.71 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$0.30 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$0.45 derived: net income ÷ weighted average shares · filed 2024-05-13 | ||||||||
| 2022-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2024-03-12 | $0.03 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$0.11 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$0.17 10-K · filed 2024-03-12 | ||||||||
| 2022-09-30 | $0.16 10-Q · filed 2023-11-14 | -$0.01 10-Q · filed 2022-11-04 | $0.03 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.04 10-Q · filed 2023-11-14 | $0.04 10-Q · filed 2022-11-04 | |||||||
| 2022-06-30 | -$0.13 10-Q · filed 2023-08-11 | $0.09 10-Q · filed 2022-08-12 | -$0.20 10-Q · filed 2023-08-11 | $0.04 10-Q · filed 2022-08-12 | ||||||||
| 2022-03-31 | -$0.07 10-Q · filed 2023-05-12 | -$0.05 10-Q · filed 2022-05-16 | ||||||||||
| 2021-12-31 | -$0.67 10-K · filed 2024-03-12 | $0.05 10-K · filed 2022-02-24 | ||||||||||
| 2021-09-30 | -$0.08 10-Q · filed 2022-11-04 | -$0.02 10-Q · filed 2022-11-04 | ||||||||||
| 2021-06-30 | -$0.01 10-Q · filed 2022-08-12 | -$0.07 10-Q · filed 2021-08-19 | $0.07 10-Q · filed 2022-08-12 | $0.31 10-Q · filed 2021-08-19 | ||||||||
| 2021-03-31 | $0.09 10-Q · filed 2022-05-16 | $0.39 10-Q · filed 2021-07-23 | ||||||||||
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 | -$0.36 10-K · filed 2023-03-07 | ||||||||||
| 2020-09-30 | $0.00 10-Q/A · filed 2021-12-08 | $0.00 10-Q/A · filed 2021-12-08 | ||||||||||
| 2020-06-30 | -$5000.00 10-Q/A · filed 2021-08-24 | |||||||||||
| 2020-03-31 | -$5000.00 10-Q · filed 2021-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |